Cargando…

Search strategies to identify reports on “off-label” drug use in EMBASE

BACKGROUND: Medications are frequently prescribed outside their regulatory approval (off-label) by physicians particularly where appropriate therapies are not available. However, the risk/benefit ratio of drugs in off-label use needs to be critically appraised because it may differ from approved on-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesgarpour, Bita, Müller, Markus, Herkner, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543848/
https://www.ncbi.nlm.nih.gov/pubmed/23272771
http://dx.doi.org/10.1186/1471-2288-12-190
_version_ 1782255708586115072
author Mesgarpour, Bita
Müller, Markus
Herkner, Harald
author_facet Mesgarpour, Bita
Müller, Markus
Herkner, Harald
author_sort Mesgarpour, Bita
collection PubMed
description BACKGROUND: Medications are frequently prescribed outside their regulatory approval (off-label) by physicians particularly where appropriate therapies are not available. However, the risk/benefit ratio of drugs in off-label use needs to be critically appraised because it may differ from approved on-label usage. Therefore, an extensive exploration of current evidence on clinical data is well-advised. The objective of this study was to develop a search strategy that facilitates detection of the off-label drug use documents in EMBASE via OvidSP. METHODS: We constructed two sets of gold standards from relevant records to off-label drug use by a sensitive search of MEDLINE and EMBASE. Search queries, including search words and strings, were conceived based on definition of off-label use of medications as well as text analysis of 500 randomly selected relevant documents. The selected terms were searched in EMBASE (from 1988 to 2011) and their retrieval performance was compared with the gold standards. We developed a sensitivity-maximizing, and a sensitivity- and precision-maximizing search strategy. RESULTS: From 4067 records relevant to off-label drug use in our full gold standard set, 3846 records were retrievable from EMBASE. “off label*.af.” was the most sensitive single term (overall sensitivity 77.5%, sensitivity within EMBASE 81.9%, precision 88.1%). The highest sensitive search strategy was achieved by combining 36 search queries with overall sensitivity of 94.0% and precision of 69.5%. An optimal sensitive and precise search strategy was yielded precision 87.4% at the expense of decreasing overall sensitivity to 89.4%. CONCLUSION: We developed highly sensitive search strategies to enhance the retrieval of studies on off-label drug use in OvidSP EMBASE.
format Online
Article
Text
id pubmed-3543848
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35438482013-01-14 Search strategies to identify reports on “off-label” drug use in EMBASE Mesgarpour, Bita Müller, Markus Herkner, Harald BMC Med Res Methodol Research Article BACKGROUND: Medications are frequently prescribed outside their regulatory approval (off-label) by physicians particularly where appropriate therapies are not available. However, the risk/benefit ratio of drugs in off-label use needs to be critically appraised because it may differ from approved on-label usage. Therefore, an extensive exploration of current evidence on clinical data is well-advised. The objective of this study was to develop a search strategy that facilitates detection of the off-label drug use documents in EMBASE via OvidSP. METHODS: We constructed two sets of gold standards from relevant records to off-label drug use by a sensitive search of MEDLINE and EMBASE. Search queries, including search words and strings, were conceived based on definition of off-label use of medications as well as text analysis of 500 randomly selected relevant documents. The selected terms were searched in EMBASE (from 1988 to 2011) and their retrieval performance was compared with the gold standards. We developed a sensitivity-maximizing, and a sensitivity- and precision-maximizing search strategy. RESULTS: From 4067 records relevant to off-label drug use in our full gold standard set, 3846 records were retrievable from EMBASE. “off label*.af.” was the most sensitive single term (overall sensitivity 77.5%, sensitivity within EMBASE 81.9%, precision 88.1%). The highest sensitive search strategy was achieved by combining 36 search queries with overall sensitivity of 94.0% and precision of 69.5%. An optimal sensitive and precise search strategy was yielded precision 87.4% at the expense of decreasing overall sensitivity to 89.4%. CONCLUSION: We developed highly sensitive search strategies to enhance the retrieval of studies on off-label drug use in OvidSP EMBASE. BioMed Central 2012-12-29 /pmc/articles/PMC3543848/ /pubmed/23272771 http://dx.doi.org/10.1186/1471-2288-12-190 Text en Copyright ©2012 Mesgarpour et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mesgarpour, Bita
Müller, Markus
Herkner, Harald
Search strategies to identify reports on “off-label” drug use in EMBASE
title Search strategies to identify reports on “off-label” drug use in EMBASE
title_full Search strategies to identify reports on “off-label” drug use in EMBASE
title_fullStr Search strategies to identify reports on “off-label” drug use in EMBASE
title_full_unstemmed Search strategies to identify reports on “off-label” drug use in EMBASE
title_short Search strategies to identify reports on “off-label” drug use in EMBASE
title_sort search strategies to identify reports on “off-label” drug use in embase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543848/
https://www.ncbi.nlm.nih.gov/pubmed/23272771
http://dx.doi.org/10.1186/1471-2288-12-190
work_keys_str_mv AT mesgarpourbita searchstrategiestoidentifyreportsonofflabeldruguseinembase
AT mullermarkus searchstrategiestoidentifyreportsonofflabeldruguseinembase
AT herknerharald searchstrategiestoidentifyreportsonofflabeldruguseinembase